Dr. Begoña Mellado

Claim this profile

Hospital Clinic I Provincial

Studies Prostate Cancer
Studies Bladder Cancer
3 reported clinical trials
7 drugs studied

Area of expertise

1Prostate Cancer
Begoña Mellado has run 2 trials for Prostate Cancer. Some of their research focus areas include:
Stage IV
BRCA positive
2Bladder Cancer
Begoña Mellado has run 1 trial for Bladder Cancer. Some of their research focus areas include:
FGFR3 positive
FGFR1 positive
Stage IV

More about Begoña Mellado

Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 0 Active Clinical Trials
Treatments Begoña Mellado has experience with
  • Prednisone
  • Abemaciclib
  • Abiraterone Acetate
  • Futibatinib
  • Pembrolizumab
  • Docetaxel

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Begoña Mellado specialize in?
Begoña Mellado focuses on Prostate Cancer and Bladder Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are BRCA positive.
Is Begoña Mellado currently recruiting for clinical trials?
No, Begoña Mellado is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Begoña Mellado has studied deeply?
Yes, Begoña Mellado has studied treatments such as Prednisone, Abemaciclib, Abiraterone Acetate.
What is the best way to schedule an appointment with Begoña Mellado?
Apply for one of the trials that Begoña Mellado is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.